Q2 2025 Compass Pathways PLC Earnings Call Transcript

Jul 31, 2025 / 12:00 PM GMT

Release Date Price: $4.35 (+10.41%)

Transcript 8-K10-Q

Key Points

Positve

Compass Pathways PLC (CMPS) announced the successful achievement of the primary endpoint in the COM 360 005 trial, demonstrating a clinically meaningful reduction in depression.
The company has delivered positive, statistically significant results from two robust late-stage studies in treatment-resistant depression (TRD), providing important clinical validation for COM 360.
Compass Pathways PLC (CMPS) is on track to disclose 26-week data from the second pivotal phase 3 trial, COM 006, in the second half of next year.
The company is preparing for a potential commercial launch by working with a broad array of mental health care providers to integrate COM 360 into existing care settings.
Compass Pathways PLC (CMPS) has a strong cash position with $222 million in cash and cash equivalents, expected to fund operations into 2027.

Negative

The company experienced a decrease in cash and cash equivalents from $260 million at the end of the first quarter to $222 million at the end of June.
There is uncertainty regarding the timeline for FDA approval and whether the second phase 3 study data will be needed before submission.
The anorexia study faced challenges with low participant numbers and high dropout rates, limiting statistical power.
The company is facing a competitive landscape with other companies also applying for the commissioner's national priority review voucher.
There are concerns about the safety profile, particularly regarding suicidality, in high-risk patient populations such as those with anorexia.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CMPS.OQ - Compass Pathways PLC
Q2 2025 Compass Pathways PLC Earnings Call
Jul 31, 2025 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello everyone and welcome to Coast Pathways 2nd quarter 2025 earnings conference call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session. If you'd like to ask a question during that time, please press star, followed by one on your telephone keypad.

Thank you. I'd no like to hand the call over to Stephen Schultz, senior Vice President of investor relations. You may now go ahead, please.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Welcome all of you and thank you for joining us today for our

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.